Current guidelines center DEXA screening on women aged 65 and older, with earlier screening for postmenopausal women who have risk factors for osteoporosis. The U.S. Preventive Services Task Force (USPSTF) reaffirmed this position in its latest recommendation statement, while acknowledging that evidence for routine screening in men remains insufficient to make a blanket call. Beyond these headline recommendations, though, there is a web of guidelines covering how results are scored, which body sites matter most, when to repeat a scan, and who falls through the cracks of the standard framework.
Who Should Get Screened
The USPSTF’s screening recommendation has two tiers for women. First, all women 65 and older should be screened for osteoporosis with a bone density test. Second, postmenopausal women younger than 65 who have at least one risk factor for osteoporosis should also be screened, with the decision guided by a clinical risk assessment tool. Risk factors that push toward earlier screening include low body weight, a history of fracture after age 50, a parent who fractured a hip, smoking, and heavy alcohol use.1USPSTF. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement
For men, the picture is less settled. The USPSTF states that the evidence is insufficient to assess the balance of benefits and harms of screening men for osteoporosis.2USPSTF. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement That does not mean men should never get a DEXA scan. The American College of Physicians recommends that clinicians periodically assess risk factors in older men and order a DEXA scan for those at increased risk who would be candidates for drug treatment.3PubMed. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians In practice, most clinicians consider screening men at age 70 and above, or younger men taking long-term corticosteroids, on androgen deprivation therapy, or with a fragility fracture history.
Understanding T-Scores and Z-Scores
A DEXA scan produces a number called bone mineral density, but the raw value in grams per square centimeter is not what you or your doctor act on. Instead, the result is translated into standardized scores that compare your bones to reference populations.
The T-score compares your bone density to that of a healthy young adult of the same sex. A T-score of 0 means you match the average young adult. A score of −1.0 to −2.4 is classified as osteopenia, meaning bone density is below normal but not yet in the osteoporosis range. A T-score of −2.5 or lower at the femoral neck defines osteoporosis.4PubMed Central. Bone mineral density: testing for osteoporosis These thresholds were established by a World Health Organization working group and have been the standard diagnostic categories since the early 1990s.5PubMed. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases
The Z-score works differently. It compares your bone density to people of the same age and sex, not to young adults. A Z-score of −2.5 or worse suggests that something beyond normal aging is pulling your bones down, and should trigger an investigation for secondary causes of bone loss such as vitamin D deficiency, celiac disease, or certain medications.6PubMed Central. Bone mineral density: testing for osteoporosis The Z-score is not used to diagnose osteoporosis in the standard sense, but it is the preferred metric for certain populations, which brings us to one of the most common points of confusion around DEXA guidelines.
Why Younger Adults Get Scored Differently
T-scores were designed for and validated in postmenopausal women. Applying them to premenopausal women or younger men can be misleading. The International Society for Clinical Densitometry (ISCD) recommends using Z-scores rather than T-scores for premenopausal women and men between 20 and 49.7PubMed. Dual-energy X-ray absorptiometry diagnostic discordance between Z-scores and T-scores in young adults The reason is straightforward: comparing a 30-year-old’s bones to the bones of a healthy 30-year-old makes more clinical sense than comparing them to a reference population they should still match anyway.
Routine bone density screening in healthy premenopausal women is not recommended. However, testing is advisable for those who have conditions or take medications that can cause secondary bone loss.8PubMed. Osteoporosis risk in premenopausal women The relationship between bone density and fracture risk in premenopausal women is not the same as in postmenopausal women, and finding low bone density in a younger woman should prompt a thorough workup for underlying causes rather than automatic treatment.9PubMed Central. Treatment of premenopausal women with low bone mineral density Standard osteoporosis drugs have not been properly evaluated in pre- or perimenopausal women with low bone density in the absence of a secondary cause.10PubMed. Bone densitometry in premenopausal women: synthesis and review
Pediatric DEXA Scans
Children and adolescents present an even more complex situation. DEXA is the most widely used tool for evaluating bone density in patients of all ages, but interpreting results during growth and development is far harder. Growing skeletons change rapidly, and there is wide individual variation in pubertal timing, hormone activity, and bone size. The ISCD developed specific pediatric positions to address this, covering patients roughly 9 to 19 years old.11PubMed. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents Comparisons in this age group can only be made against healthy subjects matched by age, sex, and ethnicity.
One practical consideration: the monitoring time interval in healthy children and adolescents varies substantially. During peak growth years, meaningful changes in bone density at the spine and total body can be detected in as little as three months. In late adolescence, as each skeletal region approaches peak bone density, the time needed to detect a real change becomes much longer and at some sites becomes impractically long.12Journal of Bone and Mineral Research. Optimal monitoring time interval between DXA measures in children
Where on Your Body the Scan Looks
A standard DEXA scan measures bone density at two main sites: the lumbar spine (the lower back) and the hip, specifically the femoral neck and total hip. These are the sites used for diagnosis and treatment decisions. The forearm (specifically the distal one-third of the radius) is measured as a third site in certain circumstances, such as when the hip or spine cannot be measured or when a patient has hyperparathyroidism.
Different skeletal sites do not always agree with each other. A person might have normal bone density at the spine but osteopenia at the hip, or vice versa. Studies of postmenopausal women found substantial disagreement in osteoporosis diagnosis when only a single site was measured, regardless of which site or technique was used.13PubMed. Comparison of bone mineral density of the phalanges, lumbar spine, hip, and forearm for the assessment of osteoporosis in postmenopausal women Among the standard sites, femoral neck bone density provides the best estimate of fracture risk in women.14PubMed. Osteoporosis assessment by whole body region vs. site-specific DXA This is why the WHO’s diagnostic threshold of −2.5 is defined at the femoral neck specifically.
Precision varies by site as well. The highest measurement consistency comes from the total hip, the total forearm, and the lumbar spine, all of which have very low coefficients of variation (around 0.5% to 1.2%).15PubMed. Precision error of fan-beam dual X-ray absorptiometry scans at the spine, hip, and forearm Good precision matters because when you return for a follow-up scan, your doctor needs to know whether any change is real or just measurement noise.
How Often to Repeat a DEXA Scan
Guidelines on rescreening intervals are less rigid than initial screening recommendations. For most postmenopausal women with normal bone density or mild osteopenia, repeating a scan every five years is a reasonable interval. A cost-effectiveness analysis of different screening strategies found that DEXA screening with a treatment threshold of T-score −2.5 or less, combined with rescreening every five years, was the best strategy below a standard willingness-to-pay threshold.16PubMed Central. Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women For a somewhat more relaxed treatment threshold of −2.0 or less, rescreening every 10 years was still cost-effective.
If you are on treatment for osteoporosis, most clinicians will repeat the scan every one to two years to see whether the medication is working. For people who are not on treatment but whose first scan showed borderline results, a two-year follow-up is common. The key constraint is that the measurement error of a DEXA scan means very small changes in bone density between visits may be noise rather than real gain or loss. Your provider should calculate the “least significant change” for your particular machine and site before concluding your bones have genuinely improved or declined.
Things That Can Throw Off Your Results
A DEXA scan reads X-ray absorption through the body, and anything in the beam’s path that does not belong to your bones can distort the reading. At the lumbar spine, degenerative changes like bone spurs, disc calcification, and arthritis are the most common culprits. In older adults, degenerative or artifact-related errors affected about 16% of lumbar spine scans, compared with less than 3% in younger adults.17PubMed. Pitfalls and sources of error in DXA reporting and interpretation: The role of age-associated comorbidities, structural changes, and artifacts These artifacts tend to inflate the spine’s apparent bone density, which can mask real osteoporosis. The hip is much less prone to this problem.
Foreign objects such as metal implants, buttons, or even thick clothing with zippers can also interfere. Calcium supplements taken shortly before a scan, barium from a recent GI study, or vertebral compression fractures can all affect the reading. Careful technique by the technologist and careful interpretation by the physician are both needed to avoid errors that reduce the scan’s clinical value.18Journal of Nuclear Medicine Technology. Improving DXA Quality by Avoiding Common Technical and Diagnostic Pitfalls: Part 1 If your spine results seem inconsistent with your hip results, your doctor should consider whether artifact is the explanation before changing treatment.
Glucocorticoids and Early Bone Loss
People taking glucocorticoid medications (prednisone, prednisolone, dexamethasone, and similar drugs) deserve a separate mention because bone loss from these drugs starts early and can be severe. Glucocorticoid-induced osteoporosis is one of the most common and serious side effects of long-term steroid use, yet patients at risk are often undertreated.19PubMed Central. Corticosteroid use in chronic dermatologic disorders and osteoporosis Guidelines from rheumatology and endocrinology societies generally recommend a baseline DEXA scan within the first six months of starting glucocorticoid therapy expected to last three months or longer, regardless of the patient’s age or sex. This is one of the clearest situations where guidelines explicitly call for DEXA scanning in younger adults and in men who would not otherwise meet screening criteria.
FRAX and When a T-Score Is Not Enough
A T-score tells you bone density, but density alone does not capture the whole picture of fracture risk. Age, sex, prior fractures, family history, steroid use, smoking, alcohol, and several other factors all contribute independently to the chance of breaking a bone. The FRAX tool, developed by the WHO, combines these clinical risk factors with or without bone density results to estimate your 10-year probability of a major osteoporotic fracture and of a hip fracture specifically.20PubMed Central. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis
FRAX can be particularly useful for people whose T-score falls in the osteopenia range, where the decision about whether to start treatment is not obvious. In U.S. practice, treatment is typically recommended when the 10-year probability of a major osteoporotic fracture reaches 20% or a hip fracture reaches 3%. FRAX also works in populations where you might not expect it. In patients with chronic kidney disease, the tool still predicted hip fractures at every stage of disease, with strong hazard ratios per standard-deviation increase in FRAX score even in those with severely reduced kidney function.21PubMed. The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease
Trabecular Bone Score
One limitation of standard DEXA is that it measures bone quantity but says little about bone quality. Two people with identical T-scores can have very different fracture risks if one has degraded internal bone architecture. The trabecular bone score (TBS) was developed to address this gap. It is a texture analysis applied to the same lumbar spine DEXA image you have already had taken, requiring no additional scan or radiation.22PubMed. Trabecular bone score: a noninvasive analytical method based upon the DXA image
TBS evaluates the variation in pixel gray levels across the spine image to estimate microarchitectural quality. Higher TBS values suggest intact, well-connected bone structure, while lower values suggest degraded architecture. Both cross-sectional and longitudinal studies have shown that TBS can independently predict fragility fractures and complements standard bone density measurement.23PubMed Central. Trabecular Bone Score-An Emerging Tool in the Management of Osteoporosis TBS has been incorporated into newer versions of the FRAX calculator, adjusting fracture risk up or down based on bone quality. It is especially useful in conditions where bone density may look deceptively normal while the bone’s internal structure has been compromised, such as in people on long-term glucocorticoids or those with type 2 diabetes.
Radiation Exposure
One of the reasons DEXA is recommended as the frontline screening tool is its extremely low radiation dose. A spine DEXA delivers roughly 0.013 millisieverts (mSv) of effective radiation, and a hip scan about 0.009 mSv.24PubMed Central. Radiation exposure in X-ray-based imaging techniques used in osteoporosis To put that in perspective, the worldwide average effective dose from natural background radiation is about 2.4 mSv per year, so a combined spine-and-hip DEXA scan delivers less than 1% of what you absorb from the environment annually. A single lumbar spine X-ray delivers roughly 50 to 70 times more radiation than a lumbar DEXA.25PubMed Central. Radiation exposure in X-ray-based imaging techniques used in osteoporosis Fan-beam technology, which is now the standard in most clinics, does give slightly higher doses than older pencil-beam systems, but the dose remains very small.26PubMed. Radiation exposure in bone mineral density assessment
Body Composition Analysis
DEXA’s capabilities extend beyond bone. The same dual-energy technology that distinguishes bone from soft tissue can also differentiate fat mass from lean mass, making DEXA a widely used tool for body composition assessment. It is considered a gold-standard technique for quantifying fat mass, lean mass, and bone mineral content at both the whole-body level and in specific regions.27PubMed. The role of DXA in sarcopenia
The ISCD’s official guidelines endorse DEXA for body composition analysis in specific clinical situations: evaluating fat distribution in HIV-positive patients on antiretroviral therapy, assessing fat and lean mass after bariatric surgery or major weight loss exceeding 10%, and evaluating patients with reduced strength or poor physical function.28Cardiovascular Prevention and Pharmacotherapy. Use of dual-energy x-ray absorptiometry for body composition in chronic disease management In the context of sarcopenia (the age-related loss of muscle mass and function), DEXA-derived measures of appendicular lean mass are used as diagnostic markers. However, the choice of which specific DEXA metric to use can dramatically change the result. One study found that sarcopenia prevalence ranged from less than 1% to more than 36% in the same cohort depending on which DEXA-derived index was applied.29PubMed Central. DXA-Derived Indices in the Characterisation of Sarcopenia This lack of standardization is worth knowing if you ever see a sarcopenia diagnosis based on a DEXA scan: the cutoff used matters as much as the measurement itself.
Radiation-Free Alternatives on the Horizon
Although DEXA remains the reference standard, emerging technologies are worth knowing about. Radiofrequency Echographic Multi Spectrometry (REMS) is a portable, radiation-free ultrasound-based approach that can assess bone density at the lumbar spine and femoral neck. A growing body of evidence shows a strong correlation between REMS and DEXA bone density measurements, and REMS has also been studied for five-year fracture prediction using a proprietary “Fragility Score” that captures bone quality alongside quantity.30PubMed Central. Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art REMS could be especially useful in settings where DEXA machines are scarce or in populations where repeat radiation, however small, is a concern. It is not yet a replacement for DEXA in most clinical guidelines, but the technology is being positioned as a complementary or alternative tool that could widen access to bone density screening in underserved areas.